Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

FHTX

Foghorn Therapeutics (FHTX)

Foghorn Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FHTX
DateTimeSourceHeadlineSymbolCompany
30/12/202423:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
16/12/202423:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
16/12/202423:00GlobeNewswire Inc.Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic PrioritiesNASDAQ:FHTXFoghorn Therapeutics Inc
12/11/202423:54GlobeNewswire Inc.Foghorn Therapeutics to Participate in Three Upcoming Investor ConferencesNASDAQ:FHTXFoghorn Therapeutics Inc
05/11/202408:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FHTXFoghorn Therapeutics Inc
05/11/202408:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
23/10/202423:00PR Newswire (US)Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering IntelligenceNASDAQ:FHTXFoghorn Therapeutics Inc
10/10/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
10/10/202422:00GlobeNewswire Inc.Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid TumorsNASDAQ:FHTXFoghorn Therapeutics Inc
09/10/202408:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FHTXFoghorn Therapeutics Inc
03/10/202422:00PR Newswire (US)Invaio Sciences Appoints André Andonian as Chairman of the Board of DirectorsNASDAQ:FHTXFoghorn Therapeutics Inc
01/10/202421:00GlobeNewswire Inc.Foghorn Therapeutics to Participate in the BMO Oncology SummitNASDAQ:FHTXFoghorn Therapeutics Inc
25/09/202406:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
21/09/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
19/09/202406:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
17/09/202406:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
12/09/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
10/09/202406:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
05/09/202406:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
05/09/202406:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
03/09/202421:00GlobeNewswire Inc.Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business OfficerNASDAQ:FHTXFoghorn Therapeutics Inc
28/08/202421:00GlobeNewswire Inc.Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in SeptemberNASDAQ:FHTXFoghorn Therapeutics Inc
08/08/202422:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FHTXFoghorn Therapeutics Inc
08/08/202421:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FHTXFoghorn Therapeutics Inc
08/08/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
06/08/202420:30PR Newswire (US)Flagship Pioneering Announces Appointment of Raj Panjabi as Senior PartnerNASDAQ:FHTXFoghorn Therapeutics Inc
04/06/202406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
28/05/202421:00GlobeNewswire Inc.Foghorn Therapeutics to Participate in Upcoming Investor Conferences in JuneNASDAQ:FHTXFoghorn Therapeutics Inc
23/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
23/05/202408:21GlobeNewswire Inc.Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance PipelineNASDAQ:FHTXFoghorn Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FHTX